Evaluation of Mitochondrial Energy Metabolism and Translation in Clear Cell Renal Cell Carcinoma

Abstract

Clear cell renal cell carcinoma (ccRCC) is one of the most common renal cell carcinomas. The defining morphological hallmark of ccRCC is the accumulation of glycogen and lipid droplets in the cytoplasm of the cells due to the reprogramming of glucose and fatty acid metabolism and oxidative phosphorylation (OXPHOS). Energy metabolism by OXPHOS is supported by both nuclear and mitochondrial‐encoded genes. Alterations in the expression of mitochondrial genes involved in OXPHOS have been well documented in ccRCC.We proposed that the mitochondrial translation machinery that exists solely for the synthesis of 13 mitochondrially‐encoded subunits of OXPHOS complexes is also implicated in the progression of ccRCC.To test this hypothesis, immunoblotting analyses of 14 ccRCC biopsies and their matched normal tissues were performed to investigate the role of mitochondrial translation machinery in the remodeling of OXPHOS complexes. Along with changes in the expression of nuclear and mitochondrial encoded subunits of OXPHOS complexes, we discovered that the expression of several mitochondrial translation factors such as mtEF‐Tu (TUFM), mtIF2 (MTIF2), and mtEF‐G (GFM1) and ribosomal proteins were also significantly reduced in ccRCC biopsies. To identify the key factors involved in mitochondrial translation further, genomics and proteomics data mining analyses of publicly available ccRCC databases at the Cancer Genome Atlas (TCGA) and The Clinical Proteomic Tumor Analysis Consortium (CPTAC) were also performed.Based on the evidence provided in our studies, we propose that changes in the expression of mitochondrial translation components, specifically translation factors and mitochondrial ribosomal proteins, are part of the remodeling of mitochondrial energy metabolism and resistance to apoptosis in ccRCC.